Industry: Medical Devices & Consumables
Published Date: 2026-01-09
Pages: 128 Pages
Report ld: 5619273
Request Sample
Customized Report
Lower Limb Artery Interventional Devices Market Size(US$)

CAGR 2026-2032
14.6%
Market Size,2032
USD 1,221
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Lower Limb Artery Interventional Devices market was valued at US$ 476 million in 2025 and is anticipated to reach US$ 1221 million by 2032, at a CAGR of 14.6% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Lower Limb Artery Interventional Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Lower extremity arterial disease refers to a disease in which localized stenosis or occlusion of lower extremity arteries causes ischemia of the body. Stenosis or occlusion of lower extremity arteries can cause symptoms such as intermittent claudication, cold skin in the legs or feet, chronic pain, and gangrene. The main cause of lower extremity arterial disease is atherosclerosis, and lesions related to atherosclerosis account for 90%-95% of all lesions. The 5-year mortality rate of patients with intermittent claudication is about 30%, while the 5-year mortality rate of patients with lower extremity ischemia with rest pain, ulcers, and gangrene is as high as 70%.
The North American market for Lower Limb Artery Interventional Devices is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Lower Limb Artery Interventional Devices is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Lower Limb Artery Interventional Devices include Boston Scientific Corporation, Cordis Corporation, Abbott, W.L. Gore & Associates, Becton, BD, Medtronic, Cook Medical, Acotec Scientific, Cardio Flow, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Lower Limb Artery Interventional Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lower Limb Artery Interventional Devices. The Lower Limb Artery Interventional Devices market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lower Limb Artery Interventional Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lower Limb Artery Interventional Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Lower Limb Artery Interventional Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Lower Limb Artery Interventional Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Lower Limb Artery Interventional Devices Market Overview
1.1 Product Definition
1.2 Lower Limb Artery Interventional Devices by Type
1.2.1 Global Lower Limb Artery Interventional Devices Market Value by Type: 2025 vs 2032
1.2.2 Balloon Angioplasty
1.2.3 Stenting
1.2.4 Endovascular Volume Reduction
1.2.5 Other
1.3 Lower Limb Artery Interventional Devices by Application
1.3.1 Global Lower Limb Artery Interventional Devices Market Value by Application: 2025 vs 2032
1.3.2 Iliac Artery
1.3.3 Femoral Artery
1.3.4 Other
1.4 Global Lower Limb Artery Interventional Devices Market Size Estimates and Forecasts
1.4.1 Global Lower Limb Artery Interventional Devices Revenue 2021–2032
1.4.2 Global Lower Limb Artery Interventional Devices Sales 2021–2032
1.4.3 Global Lower Limb Artery Interventional Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Lower Limb Artery Interventional Devices Market Competition by Manufacturers
2.1 Global Lower Limb Artery Interventional Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Lower Limb Artery Interventional Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Lower Limb Artery Interventional Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Lower Limb Artery Interventional Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Lower Limb Artery Interventional Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Lower Limb Artery Interventional Devices, Product Types and Applications
2.7 Global Key Manufacturers of Lower Limb Artery Interventional Devices, Date of Entry into the Industry
2.8 Global Lower Limb Artery Interventional Devices Market Competitive Situation and Trends
2.8.1 Global Lower Limb Artery Interventional Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Lower Limb Artery Interventional Devices Players Market Share by Revenue
2.8.3 Global Lower Limb Artery Interventional Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lower Limb Artery Interventional Devices Market Scenario by Region
3.1 Global Lower Limb Artery Interventional Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Lower Limb Artery Interventional Devices Sales by Region: 2021–2032
3.2.1 Global Lower Limb Artery Interventional Devices Sales by Region: 2021–2026
3.2.2 Global Lower Limb Artery Interventional Devices Sales by Region: 2027–2032
3.3 Global Lower Limb Artery Interventional Devices Revenue by Region: 2021–2032
3.3.1 Global Lower Limb Artery Interventional Devices Revenue by Region: 2021–2026
3.3.2 Global Lower Limb Artery Interventional Devices Revenue by Region: 2027–2032
3.4 North America Lower Limb Artery Interventional Devices Market Facts & Figures by Country
3.4.1 North America Lower Limb Artery Interventional Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Lower Limb Artery Interventional Devices Sales by Country (2021–2032)
3.4.3 North America Lower Limb Artery Interventional Devices Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lower Limb Artery Interventional Devices Market Facts & Figures by Country
3.5.1 Europe Lower Limb Artery Interventional Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Lower Limb Artery Interventional Devices Sales by Country (2021–2032)
3.5.3 Europe Lower Limb Artery Interventional Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lower Limb Artery Interventional Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Lower Limb Artery Interventional Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Lower Limb Artery Interventional Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Lower Limb Artery Interventional Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lower Limb Artery Interventional Devices Market Facts & Figures by Country
3.7.1 Latin America Lower Limb Artery Interventional Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Lower Limb Artery Interventional Devices Sales by Country (2021–2032)
3.7.3 Latin America Lower Limb Artery Interventional Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Lower Limb Artery Interventional Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Lower Limb Artery Interventional Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Lower Limb Artery Interventional Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Lower Limb Artery Interventional Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lower Limb Artery Interventional Devices Sales by Type (2021–2032)
4.1.1 Global Lower Limb Artery Interventional Devices Sales by Type (2021–2026)
4.1.2 Global Lower Limb Artery Interventional Devices Sales by Type (2027–2032)
4.1.3 Global Lower Limb Artery Interventional Devices Sales Market Share by Type (2021–2032)
4.2 Global Lower Limb Artery Interventional Devices Revenue by Type (2021–2032)
4.2.1 Global Lower Limb Artery Interventional Devices Revenue by Type (2021–2026)
4.2.2 Global Lower Limb Artery Interventional Devices Revenue by Type (2027–2032)
4.2.3 Global Lower Limb Artery Interventional Devices Revenue Market Share by Type (2021–2032)
4.3 Global Lower Limb Artery Interventional Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Lower Limb Artery Interventional Devices Sales by Application (2021–2032)
5.1.1 Global Lower Limb Artery Interventional Devices Sales by Application (2021–2026)
5.1.2 Global Lower Limb Artery Interventional Devices Sales by Application (2027–2032)
5.1.3 Global Lower Limb Artery Interventional Devices Sales Market Share by Application (2021–2032)
5.2 Global Lower Limb Artery Interventional Devices Revenue by Application (2021–2032)
5.2.1 Global Lower Limb Artery Interventional Devices Revenue by Application (2021–2026)
5.2.2 Global Lower Limb Artery Interventional Devices Revenue by Application (2027–2032)
5.2.3 Global Lower Limb Artery Interventional Devices Revenue Market Share by Application (2021–2032)
5.3 Global Lower Limb Artery Interventional Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific Corporation
6.1.1 Boston Scientific Corporation Company Information
6.1.2 Boston Scientific Corporation Description and Business Overview
6.1.3 Boston Scientific Corporation Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific Corporation Lower Limb Artery Interventional Devices Product Portfolio
6.1.5 Boston Scientific Corporation Recent Developments/Updates
6.2 Cordis Corporation
6.2.1 Cordis Corporation Company Information
6.2.2 Cordis Corporation Description and Business Overview
6.2.3 Cordis Corporation Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Cordis Corporation Lower Limb Artery Interventional Devices Product Portfolio
6.2.5 Cordis Corporation Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abbott Lower Limb Artery Interventional Devices Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 W.L. Gore & Associates
6.4.1 W.L. Gore & Associates Company Information
6.4.2 W.L. Gore & Associates Description and Business Overview
6.4.3 W.L. Gore & Associates Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 W.L. Gore & Associates Lower Limb Artery Interventional Devices Product Portfolio
6.4.5 W.L. Gore & Associates Recent Developments/Updates
6.5 Becton
6.5.1 Becton Company Information
6.5.2 Becton Description and Business Overview
6.5.3 Becton Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Becton Lower Limb Artery Interventional Devices Product Portfolio
6.5.5 Becton Recent Developments/Updates
6.6 BD
6.6.1 BD Company Information
6.6.2 BD Description and Business Overview
6.6.3 BD Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 BD Lower Limb Artery Interventional Devices Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Medtronic
6.7.1 Medtronic Company Information
6.7.2 Medtronic Description and Business Overview
6.7.3 Medtronic Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Medtronic Lower Limb Artery Interventional Devices Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 Cook Medical
6.8.1 Cook Medical Company Information
6.8.2 Cook Medical Description and Business Overview
6.8.3 Cook Medical Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Cook Medical Lower Limb Artery Interventional Devices Product Portfolio
6.8.5 Cook Medical Recent Developments/Updates
6.9 Acotec Scientific
6.9.1 Acotec Scientific Company Information
6.9.2 Acotec Scientific Description and Business Overview
6.9.3 Acotec Scientific Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Acotec Scientific Lower Limb Artery Interventional Devices Product Portfolio
6.9.5 Acotec Scientific Recent Developments/Updates
6.10 Cardio Flow
6.10.1 Cardio Flow Company Information
6.10.2 Cardio Flow Description and Business Overview
6.10.3 Cardio Flow Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Cardio Flow Lower Limb Artery Interventional Devices Product Portfolio
6.10.5 Cardio Flow Recent Developments/Updates
6.11 Zylox-Tonbridge Medical Technology
6.11.1 Zylox-Tonbridge Medical Technology Company Information
6.11.2 Zylox-Tonbridge Medical Technology Description and Business Overview
6.11.3 Zylox-Tonbridge Medical Technology Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Zylox-Tonbridge Medical Technology Lower Limb Artery Interventional Devices Product Portfolio
6.11.5 Zylox-Tonbridge Medical Technology Recent Developments/Updates
6.12 Zhejiang Barty Medical Technology
6.12.1 Zhejiang Barty Medical Technology Company Information
6.12.2 Zhejiang Barty Medical Technology Description and Business Overview
6.12.3 Zhejiang Barty Medical Technology Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Zhejiang Barty Medical Technology Lower Limb Artery Interventional Devices Product Portfolio
6.12.5 Zhejiang Barty Medical Technology Recent Developments/Updates
6.13 Shanghai Microport Endovascular Medtech(Group)
6.13.1 Shanghai Microport Endovascular Medtech(Group) Company Information
6.13.2 Shanghai Microport Endovascular Medtech(Group) Description and Business Overview
6.13.3 Shanghai Microport Endovascular Medtech(Group) Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Shanghai Microport Endovascular Medtech(Group) Lower Limb Artery Interventional Devices Product Portfolio
6.13.5 Shanghai Microport Endovascular Medtech(Group) Recent Developments/Updates
6.14 Leo Medical
6.14.1 Leo Medical Company Information
6.14.2 Leo Medical Description and Business Overview
6.14.3 Leo Medical Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Leo Medical Lower Limb Artery Interventional Devices Product Portfolio
6.14.5 Leo Medical Recent Developments/Updates
6.15 OrbusNeich Medical Group
6.15.1 OrbusNeich Medical Group Company Information
6.15.2 OrbusNeich Medical Group Description and Business Overview
6.15.3 OrbusNeich Medical Group Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 OrbusNeich Medical Group Lower Limb Artery Interventional Devices Product Portfolio
6.15.5 OrbusNeich Medical Group Recent Developments/Updates
6.16 Wei Qiang (Shanghai) Medical Technology
6.16.1 Wei Qiang (Shanghai) Medical Technology Company Information
6.16.2 Wei Qiang (Shanghai) Medical Technology Description and Business Overview
6.16.3 Wei Qiang (Shanghai) Medical Technology Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Wei Qiang (Shanghai) Medical Technology Lower Limb Artery Interventional Devices Product Portfolio
6.16.5 Wei Qiang (Shanghai) Medical Technology Recent Developments/Updates
6.17 Philips
6.17.1 Philips Company Information
6.17.2 Philips Description and Business Overview
6.17.3 Philips Lower Limb Artery Interventional Devices Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Philips Lower Limb Artery Interventional Devices Product Portfolio
6.17.5 Philips Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lower Limb Artery Interventional Devices Industry Chain Analysis
7.2 Lower Limb Artery Interventional Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lower Limb Artery Interventional Devices Production Mode & Process Analysis
7.4 Lower Limb Artery Interventional Devices Sales and Marketing
7.4.1 Lower Limb Artery Interventional Devices Sales Channels
7.4.2 Lower Limb Artery Interventional Devices Distributors
7.5 Lower Limb Artery Interventional Devices Customer Analysis
8 Lower Limb Artery Interventional Devices Market Dynamics
8.1 Lower Limb Artery Interventional Devices Industry Trends
8.2 Lower Limb Artery Interventional Devices Market Drivers
8.3 Lower Limb Artery Interventional Devices Market Challenges
8.4 Lower Limb Artery Interventional Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Lower Limb Artery Interventional Devices market is projected to grow from US$ 476 million in 2025 to US$ 1221 million by 2032, at a CAGR of 14.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 175
USD 4900.00
(Single User License)
The global Lower Limb Artery Interventional Devices market size was US$ 476 million in 2025 and is forecast to reach a readjusted size of US$ 1221 million by 2032 with a CAGR of 14.6% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 104
USD 4250.00
(Single User License)
The global market for Lower Limb Artery Interventional Devices was estimated to be worth US$ 476 million in 2025 and is projected to reach US$ 1221 million, growing at a CAGR of 14.6% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 145
USD 3950.00
(Single User License)
The global Lower Limb Artery Interventional Devices market is projected to grow from US$ 421 million in 2024 to US$ 1079 million by 2031, at a CAGR of 14.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 177
USD 4900.00
(Single User License)
The global Lower Limb Artery Interventional Devices market size was US$ 421 million in 2024 and is forecast to a readjusted size of US$ 1079 million by 2031 with a CAGR of 14.6% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 107
USD 4250.00
(Single User License)
The global market for Lower Limb Artery Interventional Devices was estimated to be worth US$ 421 million in 2024 and is forecast to a readjusted size of US$ 1079 million by 2031 with a CAGR of 14.6% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 148
USD 3950.00
(Single User License)
The global market for Lower Limb Artery Interventional Devices was valued at US$ 421 million in the year 2024 and is projected to reach a revised size of US$ 1079 million by 2031, growing at a CAGR of 14.6% during the forecast period.
Published Date: 2025-03-10
Pages: 102
USD 2900.00
(Single User License)
Lower extremity arterial disease refers to a disease in which localized stenosis or occlusion of lower extremity arteries causes ischemia of the body. Stenosis or occlusion of lower extremity arteries can cause symptoms such as intermittent claudication, cold skin in the legs or feet, chronic pain, and gangrene. The main cause of lower extremity arterial disease is atherosclerosis, and lesions related to atherosclerosis account for 90%-95% of all lesions. The 5-year mortality rate of patients with intermittent claudication is about 30%, while the 5-year mortality rate of patients with lower extremity ischemia with rest pain, ulcers, and gangrene is as high as 70%.
Published Date: 2024-10-01
Pages: 142
USD 4350.00
(Single User License)
Lower extremity arterial disease refers to a disease in which localized stenosis or occlusion of lower extremity arteries causes ischemia of the body. Stenosis or occlusion of lower extremity arteries can cause symptoms such as intermittent claudication, cold skin in the legs or feet, chronic pain, and gangrene. The main cause of lower extremity arterial disease is atherosclerosis, and lesions related to atherosclerosis account for 90%-95% of all lesions. The 5-year mortality rate of patients with intermittent claudication is about 30%, while the 5-year mortality rate of patients with lower extremity ischemia with rest pain, ulcers, and gangrene is as high as 70%.
Published Date: 2024-10-01
Pages: 100
USD 2900.00
(Single User License)
Lower extremity arterial disease refers to a disease in which localized stenosis or occlusion of lower extremity arteries causes ischemia of the body. Stenosis or occlusion of lower extremity arteries can cause symptoms such as intermittent claudication, cold skin in the legs or feet, chronic pain, and gangrene. The main cause of lower extremity arterial disease is atherosclerosis, and lesions related to atherosclerosis account for 90%-95% of all lesions. The 5-year mortality rate of patients with intermittent claudication is about 30%, while the 5-year mortality rate of patients with lower extremity ischemia with rest pain, ulcers, and gangrene is as high as 70%.
Published Date: 2024-10-01
Pages: 168
USD 4900.00
(Single User License)
The global Lower Limb Artery Interventional Devices market is projected to grow from US$ 476 million in 2025 to US$ 1221 million by 2032, at a CAGR of 14.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 175
The global Lower Limb Artery Interventional Devices market size was US$ 476 million in 2025 and is forecast to reach a readjusted size of US$ 1221 million by 2032 with a CAGR of 14.6% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 104
The global market for Lower Limb Artery Interventional Devices was estimated to be worth US$ 476 million in 2025 and is projected to reach US$ 1221 million, growing at a CAGR of 14.6% from 2026 to 2032.
Published: 2026-01-09
Pages: 145
The global Lower Limb Artery Interventional Devices market is projected to grow from US$ 421 million in 2024 to US$ 1079 million by 2031, at a CAGR of 14.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 177
The global Lower Limb Artery Interventional Devices market size was US$ 421 million in 2024 and is forecast to a readjusted size of US$ 1079 million by 2031 with a CAGR of 14.6% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 107
The global market for Lower Limb Artery Interventional Devices was estimated to be worth US$ 421 million in 2024 and is forecast to a readjusted size of US$ 1079 million by 2031 with a CAGR of 14.6% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 148
The global market for Lower Limb Artery Interventional Devices was valued at US$ 421 million in the year 2024 and is projected to reach a revised size of US$ 1079 million by 2031, growing at a CAGR of 14.6% during the forecast period.
Published: 2025-03-10
Pages: 102
Lower extremity arterial disease refers to a disease in which localized stenosis or occlusion of lower extremity arteries causes ischemia of the body. Stenosis or occlusion of lower extremity arteries can cause symptoms such as intermittent claudication, cold skin in the legs or feet, chronic pain, and gangrene. The main cause of lower extremity arterial disease is atherosclerosis, and lesions related to atherosclerosis account for 90%-95% of all lesions. The 5-year mortality rate of patients with intermittent claudication is about 30%, while the 5-year mortality rate of patients with lower extremity ischemia with rest pain, ulcers, and gangrene is as high as 70%.
Published: 2024-10-01
Pages: 142
Lower extremity arterial disease refers to a disease in which localized stenosis or occlusion of lower extremity arteries causes ischemia of the body. Stenosis or occlusion of lower extremity arteries can cause symptoms such as intermittent claudication, cold skin in the legs or feet, chronic pain, and gangrene. The main cause of lower extremity arterial disease is atherosclerosis, and lesions related to atherosclerosis account for 90%-95% of all lesions. The 5-year mortality rate of patients with intermittent claudication is about 30%, while the 5-year mortality rate of patients with lower extremity ischemia with rest pain, ulcers, and gangrene is as high as 70%.
Published: 2024-10-01
Pages: 100
Lower extremity arterial disease refers to a disease in which localized stenosis or occlusion of lower extremity arteries causes ischemia of the body. Stenosis or occlusion of lower extremity arteries can cause symptoms such as intermittent claudication, cold skin in the legs or feet, chronic pain, and gangrene. The main cause of lower extremity arterial disease is atherosclerosis, and lesions related to atherosclerosis account for 90%-95% of all lesions. The 5-year mortality rate of patients with intermittent claudication is about 30%, while the 5-year mortality rate of patients with lower extremity ischemia with rest pain, ulcers, and gangrene is as high as 70%.
Published: 2024-10-01
Pages: 168
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now